Clinical Trial Update: Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of the live biotherapeutic GB104 in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer
• Rectosigmoid Junction Cancer
• Sigmoid Colon Cancer

Drugs mentioned

• GB104

Snippet

Sponsor: GILongevity | Conditions: Solid Tumor, Colorectal Cancer | Phase 1 | Status: COMPLETED